secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0001641172-25-002858
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech receives NYSE American delisting notice for low stock price; plans appeal
--------------------------------------------------------------------------------

- Received notice on April 4, 2025 from NYSE American of suspension and delisting under Section 1003(f)(v) due to low selling price.
- Company will appeal the delisting determination to the Listing Qualifications Panel; no guarantee of success.
- Common stock expected to begin trading on the Pink Open Market on April 7, 2025.
- Trading on NYSE American has been suspended effective April 4, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000164117225002858/0001641172-25-002858-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000164117225002858/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002858

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer